ISRCTN93110271
Active, Not Recruiting
N/A
ReCerf Hip Resurfacing Clinical Investigation
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- End-stage joint disease e.g. osteoarthritis, requiring hip joint replacement
- Sponsor
- MatOrtho Limited
- Enrollment
- 78
- Status
- Active, Not Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient suitable for hip resurfacing arthroplasty
- •2\. Patient able to give informed consent
- •3\. Patient willing and able to take part in the study for the prescribed length of the study
- •4\. Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the study
- •5\. Minimum age of 18 years
Exclusion Criteria
- •1\. Patient deemed unsuitable for hip resurfacing arthroplasty by the surgeon
- •2\. Patient has significant contraindications when following the manufacturer's Instruction For Use of the product
- •3\. Patient likely to become incapacitated during the study
- •4\. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant’s ability to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
N/A
To evaluate the clinical outcome of a ceramic-on-ceramic hip resurfacing arthroplasty using the ceramic, non-porous, non-cemented H1 Hip Resurfacing ArthroplastyHip arthroplastySurgeryISRCTN91554748Embody Orthopaedic Limited250
Completed
N/A
Clinical study- Revelation® Hip SystemJPRN-UMIN000006107Shonan Kamakura Joint Reconstruction Center100
Completed
N/A
Primary Birmingham Hip Resurfacing Arthroplasty Using a Metal-on-Metal Couple in the Young Active PatientIndications for a Total Hip ProsthesisNCT00285948University Hospital, Ghent250
Completed
Phase 3
Durom(R) Hip Resurfacing System Multicenter TrialAdvanced Hip DiseaseNCT00746616Zimmer Biomet40
Not Yet Recruiting
N/A
Pilot: Use of Rotem in revisions of hip arthroplasties: Changes in coagulation parameters?blood coagulationfibrinogen10005944NL-OMON40640Isala Klinieken15